Inflammation as a driving force of neurodegeneration. Fundamentals of personalized diagnostics and treatment
https://doi.org/10.58708/2074-2088.2024-2(32)-15-22
Abstract
The CNS integrates efferent signals from the somatic and autonomic parts. Also the CNS also receives information from the periphery about inflammation and infection. Cytokines, chemokines and damage-associated soluble mediators of systemic inflammation can also enter the CNS via the blood and/or lymphatic systems. At the same time these substances can penetrate directly through periventricular structures, as well as by increasing the permeability of the blood-brain barrier and disrupt the healthy functioning of neurons and glia, leading to a violation of brain homeostasis. This can lead to the onset of a neurodegenerative disease or worsen its clinical symptoms. In this publication, we present current international scientific data indicating a link between the neurodegenerative process and immune disorders. In addition to identifying immune-mediated pathways of neurodegeneration, new, potentially significant, immunomodulatory targets are presented for the development of possible effective therapy for this group of diseases.
About the Authors
E. V. Vist
ИПКП кадров здравоохранения УО «Белорусский государственный медицинский университет»
Belarus
Belarus
A. V. Boika
ИПКП кадров здравоохранения УО «Белорусский государственный медицинский университет»
Belarus
Belarus
M. M. Sialitski
ИПКП кадров здравоохранения УО «Белорусский государственный медицинский университет»
Belarus
Belarus
References
1. Microglia are polarized to M1 type in highanxiety inbred mice in response to lipopolysaccharide challenge / Z. Li [et al.] // Brain Behav. Immun. – 2014. – Vol.38. – P. 237-248. doi:10.1016/j.bbi.2014.02.008
2. Long-term cognitive impairment and functional disability among survivors of severe sepsis / T.J. Iwashyna [et al.] // JAMA. – 2010. – Vol. 304. – P. 1787-1794. doi:10.1001/jama.2010.1553
3. Systemic inflammation and disease progression in Alzheimer disease / C. Holmes [et al.] // Neurology 2009. – Vol. 73. – P. 768-774. doi:10.1212/WNL.0b013e3181b6bb95
4. Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain / B. Brugg [et al.] // Proc. Natl. Acad. Sci. U.S.A. 1995. – Vol. 92. – P. 3032-3035. doi:10.1073/pnas.92.7.3032
5. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurode-generative disease / C. Cunningham [et al.] // Biol. Psychiatry 2009. – Vol. 65. – P. 304-312. doi:10.1016/j.biopsych.2008.07.024
6. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson’s disease / M.C. Pott Godoy [et al.] // Brain 2008. – Vol.131(Pt 7). – P. 1880-1894. doi:10.1093/brain/awn101
7. A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs / S. Achard [et al.] // J. Neurosci. 2006. – Vol. 26. – P. 63-72. doi:10.1523/JNEUROSCI.3874-05.2006
8. Bullmore, E. Complex brain networks: graph theoretical analysis of structural and functional systems / E. Bullmore, O. Sporns // Nat. Rev. Neurosci. – 2009. – Vol. 10. – P. 186-198. doi:10.1038/nrn2575
9. Mapping the human connectome / A.W. Toga [et al.] // Neurosurgery. – 2012. – Vol. 71. – P. 1-5. doi:10.1227/NEU.0b013e318258e9ff
10. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity / U. Fünfschilling [et al.] // Nature. – 2012. – Vol. 485. – P. 517-521. doi:10.1038/nature11007
11. Oligodendroglia metabolically support axons and contribute to neurodegeneration / Y. Lee [et al.] // Nature. – 2012. – Vol. 487. – P. 443-448. doi:10.1038/nature11314
12. Brain lesions in septic shock: a magnetic resonance imaging study / T. Sharshar [et al.] // Intensive Care Med. – 2007. – Vol. 33. – P. 798-806. doi:10.1007/s00134-007-0598-y
13. The relationship between delirium duration, white matter integrity, and cognitive impairment in intensive care unit survivors as determined by diffusion tensor imaging: the VISIONS prospective cohort magnetic resonance imaging study / A. Morandi [et al.] // Crit. Care Med. – 2012. – Vol. 40 – P. 2182-2189.doi:10.1097/CCM.0b013e318250acdc
14. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors / A. Semmler [et al.] // J. Neurol. Neurosurg. Psychiatr. – 2013. – Vol. 84. – P. 62-69. doi:10.1136/jnnp-2012-302883
15. Sepsis induces brain mitochondrial dysfunction / J.C. d’Avila [et al.] // Crit. Care Med. – 2008. – Vol. 36. – P. 1925-1932. doi:10.1097/CCM.0b013e3181760c4b
16. Alterations in inflammatory mediators, oxidative stress parameters and energetic metabolism in the brain of sepsis survivor rats / C.M. Comim [et al.] // Neurochem. Res. – 2011. – Vol. 36. – P. 304-311. doi:10.1007/s11064-010-0320-2
17. Singer, M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure / M. Singer // Virulence. – 2014. – Vol. 5. – P. 66-72. doi:10.4161/viru.26907
18. Understanding brain dysfunction in sepsis / R. Sonneville [et al.] // Ann. Intensive Care. – 2013. – Vol. 3. – P. 15. doi:10.1186/2110-5820-3-15
19. Ben Salem, C. The pathogenesis of the antiphospholipid syndrome / C. Ben Salem / N. Engl. J. Med. – 2013. – Vol. 368. – P. 2334. doi:10.1056/NEJMc1304515
20. Million, M. The pathogenesis of the antiphospholipid syndrome / M. Million, D. Raoult // N. Engl. J. Med. – 2013. – Vol. 368. – P. 2335. doi:10.1056/NEJMc1300484
21. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings / M.G. Tektonidou [et al.] // Arch. Intern. Med. – 2006. – Vol. 166. – P. 2278-2284. doi:10.1001/archinte.166.20.2278
22. Cerebral changes in SLE with or without antiphospholipid syndrome. A case-control MRI study / S.I. Valdés-Ferrer [et al.] // J. Neuroimaging. – 2008. – Vol. 18. – P. 62-65. doi:10.1111/j.1552-6569.2007.00183.x
23. Medzhitov, R. Disease tolerance as a defense strategy / R. Medzhitov, D.S. Schneider, M.P. Soares // Science. – 2012. – Vol. 335. – P. 936-941. doi:10.1126/science.1214935
24. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. / M. Schwartz, K. Baruch // EMBO J. – 2014. – Vol. 33. – P. 7-22. doi:10.1002/embj.201386609
25. Immunogenic and tolerogenic cell death / D.R. Green [et al.] // Nat. Rev. Immunol. – 2009. – Vol. 9. – P. 353-363. doi:10.1038/nri2545
26. Zitvogel, L. Decoding cell death signals in inflammation and immunity / L. Zitvogel, O. Kepp, G. Kroemer // Cell. – 2010. – Vol. 140. – P. 798-804. doi:10.1016/j.cell.2010.02.015
27. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases / F. Martinon, J. Tschopp // Cell. – 2004. – Vol. 117. P. 561-574. doi:10.1016/j.cell.2004.05.004
28. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice / M.T. Heneka [et al.] // Nature. – 2013. – Vol. 493. – P. 674-678. doi:10.1038/nature11729
29. Caspase signalling controls microglia activation and neurotoxicity / M.A. Burguillos [et al.] // Nature. – 2011. – Vol. 472. – P. 319-324. doi:10.1038/nature09788
30. Yee, C. The intrinsic apoptosis pathway mediates the pro-longevity response to mitochondrial ROS in C. elegans / C. Yee, W. Yang, S. Hekimi // Cell. – 2014. – Vol. 157. – P. 897-909. doi:10.1016/j.cell.2014.02.055
31. IL-18 associates to microvesicles shed from human macrophages by a LPS/TLR-4 independent mechanism in response to P2X receptor stimulation / S. Gulinelli [et al.] // Eur. J. Immunol. – 2012. – Vol. 42. – P. 3334-3345. doi:10.1002/eji.201142268
32. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation / C. Verderio [et al.] // Ann. Neurol. – 2012. – Vol. 72. – P. 610-624. doi:10.1002/ana.23627
33. Microglia convert aggregated amyloid-[beta] into neurotoxic forms through the shedding of microvesicles / P. Joshi [et al.] // Cell Death Differ. – 2014. – Vol. 21. – P. 582-593. doi:10.1038/cdd.2013.180
34. Rego, A.C. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases / A.C. Rego, C.R. Oliveira // Neurochem. Res. – 2003. – Vol. 28. – P. 1563-1574. doi:10.1023/A:1025682611389
35. Green, D.R. The pathophysiology of mitochondrial cell death / D.R. Green, G. Kroemer // Science. – 2004. – Vol. 305. – P. 626-629. doi:10.1126/science.1099320
36. Greenlund, L. J. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death / L.J. Greenlund, T.L. Deckwerth, E.M.Jr. Johnson // Neuron 1995. – Vol. 14. – P. 303-315. doi:10.1016/0896-6273(95)90287-2
37. Microglia-derived proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1beta induce Purkinje neuronal apoptosis via their receptors in hypoxic neonatal rat brain / C. Kaur [et al.] // Brain Struct. Funct. – 2014. – Vol. 219. – P. 151-170. doi:10.1007/s00429-012-0491-5
38. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. / O. Aktas [et al.] // Neuron. – 2005. – Vol. 46. – P. 421- 432. doi:10.1016/j.neuron.2005.03.018
39. Depressive-like behavior induced by tumor necrosis factor-α in mice / M.P. Kaster [et al.] // Neuropharmacology. – 2012. – Vol. 62. – P. 419-426. doi:10.1016/j.neuropharm.2011.08.018
40. From inflammation to sickness and depression: when the immune system subjugates the brain / R. Dantzer [et al.] // Nat. Rev. Neurosci. – 2008. – Vol. 9. – P. 46-56. doi:10.1038/nrn2297
41. Block, M.L. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms / M.L. Block, L. Zecca, J.S. Hong // Nat. Rev. Neurosci. – 2007. – Vol. 8. – P. 57-69. doi:10.1038/nrn2038
42. Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer’s disease / X. Liang [et al.] // J. Neurosci. 2005. – Vol. 25. – P. 10180-10187. doi:10.1523/JNEUROSCI.3591-05.2005
43. Prostaglandin signaling suppresses beneficial microglial function in Alzheimer’s disease models / J.U. Johansson [et al.] // J. Clin. Invest. – 2015. – Vol. 125. – P. 350-364. doi:10.1172/JCI77487
44. Schmitt, C. Brain leukocyte infiltration initiated by peripheral inflammation or experimental autoimmune encephalomyelitis occurs through pathways connected to the CSF-filled compartments of the forebrain and midbrain / C. Schmitt, N. Strazielle, J.F. Ghersi- Egea // J. Neuroinflammation. – 2012. – Vol. 9. – P. 187. doi:10.1186/1742-2094-9-187
45. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases / H. Neumann [et al.] // Trends Neurosci. – 2002. – Vol. 25. – P. 313-319. doi:10.1016/S0166-2236(02)02154-9
46. Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue. / R. Nitsch [et al.] // J. Neurosci. – 2004. – Vol. 24. – P. 2458-2464. doi:10.1523/JNEUROSCI.4703-03.2004
47. Brain-reactive antibodies and disease / B. Diamond [et al.] // Annu. Rev. Immunol. – 2013. – Vol. 31. – P. 345-385. doi:10.1146/annurev-immunol-020711-075041
48. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications / B.F. Popescu [et al.] // Neurology. – 2011. – Vol. 76. – P. 1229-1237. doi:10.1212/WNL.0b013e318214332c
49. Evidence for stroke-induced neurogenesis in the human brain / K. Jin [et al.] // Proc. Natl. Acad. Sci. U.S.A. – 2006. – Vol. 103. – P. 13198-13202. doi:10.1073/pnas.0601164103
50. Lazarov, O. Neurogenesis and Alzheimer’s disease: at the crossroads / O. Lazarov, R.A. Marr // Exp. Neurol. – 2010. – Vol. 223. – P. 267-281. doi:10.1016/j.expneurol.2009.08.009
51. Sahay, A. Adult hippocampal neurogenesis in depression / A. Sahay, R. Hen // Nat. Neurosci. – 2007. – Vol. 10. – P. 1110-1115. doi:10.1038/nn1969
52. Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis / S. Kotani [et al.] // Chem. Biol. Interact. – 2008. – Vol. 175. – P. 227-230. doi:10.1016/j.cbi.2008.04.004
53. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants / L. Santarelli [et al.] // Science. – 2003. – Vol. 301. – P. 805-809. doi:10.1126/science.1083328
54. Monje, M.L. Inflammatory blockade restores adult hippocampal neurogenesis / M.L. Monje, H. Toda, T.D. Palmer // Science. – 2003. – Vol. 302. – P. 1760-1765. doi:10.1126/science.1088417
Supplementary files
Review
For citations:
Vist E.V., Boika A.V., Sialitski M.M. Inflammation as a driving force of neurodegeneration. Fundamentals of personalized diagnostics and treatment. Medical and Biological Problems of Life Activity. 2024;(2):15-22. (In Russ.) https://doi.org/10.58708/2074-2088.2024-2(32)-15-22
Views: 76
Email this article 